The Netherlands: ScreenPoint Medical appoints Koeniguer as new CEO

Mark Koeniguer, the new CEO of ScreenPoint Medical BV, the developers of Transpara breast AI.

ScreenPoint Medical, a company using AI to reduce the death toll caused by breast cancer, has appointed Mark Koeniguer as its new CEO to lead the next phase of growth and accelerate the company’s international expansion. Koeniguer, who has extensive experience leading and growing technology companies, took on the role on February 21, replacing ScreenPoint’s founder, Nico…

You must be a HMI Subscriber to view this content.

Subscribe Now »